Use of ??-Lactam/??-Lactamase Inhibitor Combinations to Treat Nosocomial Pneumonia

Ampicillin/sulbactam: Its potential use in treating infections in critically ill patients

“…90%) [57][58][59][60]. However, when the same dose was used in studies involving critically ill patients with more resistant strains of A. baumannii, the success rate was lower, with only 68% of patients improving on therapy [4].…”

Improving antimicrobial use in critically ill patients

“…90%) [187][188][189][190]. However, when the same dose was used in studies involving critically ill patients with more resistant strains of A. baumannii, the success rate was lower, with only 68% of patients improving on therapy [136].…”